DE68917727D1 - Verfahren zum regeln der absorptionsrate von arzneimitteln sowie arzneimittelformulierung. - Google Patents

Verfahren zum regeln der absorptionsrate von arzneimitteln sowie arzneimittelformulierung.

Info

Publication number
DE68917727D1
DE68917727D1 DE68917727T DE68917727T DE68917727D1 DE 68917727 D1 DE68917727 D1 DE 68917727D1 DE 68917727 T DE68917727 T DE 68917727T DE 68917727 T DE68917727 T DE 68917727T DE 68917727 D1 DE68917727 D1 DE 68917727D1
Authority
DE
Germany
Prior art keywords
absorption rate
acid derivative
regulating
compound
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68917727T
Other languages
English (en)
Other versions
DE68917727T2 (de
Inventor
Pertti J Neuvonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE68917727D1 publication Critical patent/DE68917727D1/de
Publication of DE68917727T2 publication Critical patent/DE68917727T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Small-Scale Networks (AREA)
  • Exhaust-Gas Circulating Devices (AREA)
  • Automatic Tape Cassette Changers (AREA)
DE68917727T 1988-02-16 1989-02-15 Verfahren zum regeln der absorptionsrate von arzneimitteln sowie arzneimittelformulierung. Expired - Fee Related DE68917727T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI880712A FI89004C (fi) 1988-02-16 1988-02-16 Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
PCT/FI1989/000024 WO1989007439A1 (en) 1988-02-16 1989-02-15 Process for regulating the absorption rate of drugs and a pharmaceutical formulation

Publications (2)

Publication Number Publication Date
DE68917727D1 true DE68917727D1 (de) 1994-09-29
DE68917727T2 DE68917727T2 (de) 1995-04-06

Family

ID=8525923

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68917727T Expired - Fee Related DE68917727T2 (de) 1988-02-16 1989-02-15 Verfahren zum regeln der absorptionsrate von arzneimitteln sowie arzneimittelformulierung.

Country Status (6)

Country Link
EP (1) EP0414688B1 (de)
AT (1) ATE110266T1 (de)
AU (1) AU3062389A (de)
DE (1) DE68917727T2 (de)
FI (2) FI89004C (de)
WO (1) WO1989007439A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533162A1 (de) * 1995-09-08 1997-03-13 Bayer Ag Pharmazeutisches Kombinationspräparat mit Ketoprofen
TW430561B (en) * 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet
AU2006226293B2 (en) 2005-03-22 2011-04-07 Losan Pharma Gmbh Solubilized ibuprofen
EP1800667A1 (de) 2005-12-23 2007-06-27 Losan Pharma GmbH Schnell lösliches Ibuprofen-Granulat
US11135188B2 (en) 2009-05-11 2021-10-05 Bayer Healthcare Llc Method and composition to improve absorption of therapeutic agents
JP2014098009A (ja) * 2014-01-29 2014-05-29 Ss Pharmaceut Co Ltd 経口用イブプロフェン製剤
CA3201462A1 (en) 2020-11-13 2022-05-19 Bayer Healthcare Llc Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217340A (en) * 1979-03-21 1980-08-12 Merck & Co., Inc. Rapid acting combination of phenyl benzoic acid compounds and magnesium hydroxide
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
DE3151196A1 (de) * 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
CA1234761A (en) * 1984-08-10 1988-04-05 Herbert Lapidus Chewable aspirin and buffering material tablet and method for producing same

Also Published As

Publication number Publication date
EP0414688B1 (de) 1994-08-24
FI906237A0 (fi) 1990-12-18
DE68917727T2 (de) 1995-04-06
FI880712A (fi) 1989-08-17
FI89004C (fi) 1993-08-10
FI89004B (fi) 1993-04-30
EP0414688A1 (de) 1991-03-06
FI89240B (fi) 1993-05-31
AU3062389A (en) 1989-09-06
FI880712A0 (fi) 1988-02-16
ATE110266T1 (de) 1994-09-15
FI89240C (fi) 1993-09-10
WO1989007439A1 (en) 1989-08-24

Similar Documents

Publication Publication Date Title
EG17609A (en) Process for preparation of therapeutic agents from derivatives of propoimic acid.
EP0461630A3 (en) Production process of microspheres
ATE16889T1 (de) Aeusserlich anwendbares, ibuprofen enthaltendes arzneimittel und verfahren zu seiner herstellung.
DE59008238D1 (de) 4-Hydroxytetrahydropyran-2-one sowie die entsprechenden Dihydroxycarbonsäurederivate, Salze und Ester, Verfahren zu ihrer Herstellung, pharmazeutische Präparate sowie Vorprodukte.
NO176082C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel
FI913949A (fi) Menetelmä substituoidun karboksyylihapon farmaseuttisesti käyttökelpoisen kodeiinisuolan valmistamiseksi
YU221889A (en) Process for producing new pharmaceutical mixture
DE68917727D1 (de) Verfahren zum regeln der absorptionsrate von arzneimitteln sowie arzneimittelformulierung.
IL90056A (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
HUT58048A (en) Process for producing 3,3'-dithio-bis(propionic acid) derivatives and their esters, as well as pharmaceutical compositions comprising same
ES2078251T3 (es) Sistema para la distribucion regulada de agentes activos y proceso para su preparacion.
ZA895959B (en) New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof,a process for the preparation thereof,the use thereof as medicinal agents,pharmaceutical products and intermediates
ES2104193T3 (es) Procedimiento para la preparacion de acidos 4,5-difluoro-benzoicos, derivados de acidos 4,5-difluoro-benzoicos y 4,5-difluoro-benzaldehidos.
EP0389773A3 (de) Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO)
PT78931B (en) Process for the preparation of 2-formylamino)-n-(1h-tetrazol-5-yl)benzamide and method for the administration thereof
JPS5481255A (en) Steroid derivative
JPS57203035A (en) Carboxylic acid ester
FR2592653A1 (fr) Derives de chromene, procede d'obtention et compositions pharmaceutiques.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee